{"cluster": 20, "subcluster": 75, "abstract_summ": "The analyses showed that tests using the S antigen are more sensitive than N antigen-based tests.We identified nine independent studies, of which six were based on commercial ELISA or CMIA/CLIA assays, and three on in-house tests.We simulate the number of RT-PCR tests required by the screening strategy and the undetected ongoing infections in a pseudo-population of 500000 subjects, under different prevalence scenarios and assuming a sensitivity of the serological test ranging from 0.50 to 0.80 (specificity=0.98).However, there is scarce information about the usefulness of rapid tests based on immunochromatography.Although Nucleic Acid Test (NAT) is considered to be the gold standard, serological tests based on antibodies could be very helpful.", "title_summ": "Evaluating COVID-19 screening strategies based on serological testsAntibody tests in detecting SARS-CoV-2 infection: a meta-analysisEvaluating the adequacy of Prima Covid-19 IgG/IgM Rapid Test for the assessment of exposure to SARS-CoV-2 virusMeta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies and public health implicationsImmunochromatographic assays for COVID-19 epidemiological screening: our experienceRapid diagnosis of SARS-CoV-2 infection by detecting IgG and IgM antibodies with an immunochromatographic device: a prospective single-center studyAn evaluation of COVID-19 serological assays informs future diagnostics and exposure assessmentDiagnostic accuracy of serological tests for covid-19: systematic review and meta-analysisAntibody Tests in Detecting SARS-CoV-2 Infection: A Meta-AnalysisReview of Current Advances in Serologic Testing for COVID-19Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: a prospective single-center studyClinical Performance of Two SARS-CoV-2 Serologic AssaysValidation and performance of a quantitative IgG assay for the screening of SARS-CoV-2 antibodiesTowards the next phase: evaluation of serological assays for diagnostics and exposure assessment.Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications.Evaluation of COVID-19 IgG/IgM Rapid Test from Orient Gene Biotech.Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for Covid-19: A meta-analysis.", "title_abstract_phrases": "Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies and public health implicationsSerology-based tests have become a key public health element in the COVID-19 pandemic to assess the degree of herd immunity that has been achieved in the population.The analyses showed that tests using the S antigen are more sensitive than N antigen-based tests.We simulate the number of RT-PCR tests required by the screening strategy and the undetected ongoing infections in a pseudo-population of 500000 subjects, under different prevalence scenarios and assuming a sensitivity of the serological test ranging from 0.50 to 0.80 (specificity=0.98).We identified nine independent studies, of which six were based on commercial ELISA or CMIA/CLIA assays, and three on in-house tests.STUDY REGISTRATION: PROSPERO CRD42020179452.Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-AnalysisThe emergence of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 made imperative the need for diagnostic tests that can identify the infection."}